SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma recalls 17,554 bottles of nasal spray from US market

22 Feb 2018 Evaluate

Sun Pharmaceutical Industries’ US arm - Sun Pharmaceutical Industries Inc (collectively Sun Pharma) is recalling over 17.5 thousand bottles of antihistamine Azelastine HCI nasal solution from the US market.  The company is recalling 17,554 bottles of Azelastine HCI Nasal Solution (Nasal Spray) 0.1 per cent (137 mcg per spray), 30 ml indicated for the treatment of the symptoms of seasonal allergic rhinitis.

The ongoing nationwide voluntary recall is a class III recall and is being recalled, following a failure to meet the %RSD requirement in the test for Droplet Size during the 6 month long term stability test station.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.


Sun Pharma. Inds. Share Price

1904.65 33.10 (1.77%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: